Or I could be completely wrong and it may beat the daylight out of Apple Watch, Samsung and other strong competitors. marketing & admin costs will balloon ahead of revenues I have not heard of any patent protection. The risk is that it is copied very quickly and it becomes a me-too product. the product is manufactured in China on contract. there will inevitably be glitches following launch (maybe not as severe as recent news of Samsung batteries blowing up!) Will they stand out from the competition, and for how long? Why did I sell out? Because looking ahead, the risks are high. CTAG is in recruitment mode, recruiting staff to ramp up marketing, sales and support. The types of wrist wearables and the range of prices is very large with lots of companies making strong pitches. If you are serious I recommend you go to Amazon first and search 'wrist wearables'. I believe the latest timeline is 4Q 2016. he has secured two major distribution agreements in the US which are impressive He has previously launched medical products grew the company and sold it to private equity Amit Ben-Haim, their CEO, has a strong reputation, and has form. It means that it will be almost as accurate as the equipment used by hospitals. CTAG claims to be the only wearable that will be medical-grade in monitoring heart conditions. Perhaps I can add some meat to your note. Around 200% profit is good enough for me. Bought various tranches between 2.25p and 3p. I spotted this company in March this year. He has expertise in risk and regulatory compliance for listed companies and is a director of SB Corporate Finance Partners Limited which is authorised by the Financial Conduct Authority to advise on and/or arrange certain investments in the UK. Amit’s experience extends across various industries including aviation (private and commercial), infrastructure, corporate finance and wealth management. In 1996, he co-established Impulse Dynamics Inc., another medical devices company, which ultimately licensed its cardiac contractility technology to NYSE-listed Guidant Corporation (a group company of Boston Scientific) and in 1998 he was one of several founders of Odigo Inc., a communications company specialising in instant messaging platforms (for example Blackberry’s BBM) which was sold in 2002 to NASDAQ-listed Comverse Inc. In 1993, he co-founded Biosense Inc., a medical devices company which was sold to Dow Jones-listed Johnson & Johnson in 1997 for $485 million. Oscar247, look at the guy who's running the show.Īmit Ben-Haim has a proven track record as a successful entrepreneur establishing, leading and expanding companies through to trade sale exits as co-founder, executive and non-executive director. The wearable arena is forecast to be worth $34 billion by 2020 and will experience a compound annual growth rate of 20.3%, culminating in 213.6 million units shipped in 2020īy looking at the innovators and founding share holders I bring insight into the experience and careers of the illustrious Board of Directors so you can understand how rare & exciting this investment opportunity truly is: To give you an idea of scale for the product, CloudTag is the first wearable device to focus its offering clearly on the weight-loss market, which is arguably the largest niche market within wearable. The product is as exciting as its location of concept and development.Īfter seven years in development the launch of CloudTag’s first product the CloudTag Track is due to be released for sale in the USA, UK & GERMANY imminently (See page 6 here) Discussions of exclusive launch dates are on going with the biggest retailers & e-tailers in these territories – announced by CEO Amit Ben-Haim in an Exclusive interview with VOX Markets on Wednesday 25th August 2016. I've been looking into this company and recently bought in, might be worth a look if anyone is interestedĬloudTag INC is supported by a uniquely formidable team of business veterans and I want to take you on a journey from the very beginning when M圜loudTag started out as an idea on the back of a napkin in 2009 and turned into something much more promising a year later at the South Pole.
0 Comments
Leave a Reply. |